Co-developed Casgevy with Vertex Pharmaceuticals — the world's first approved CRISPR gene editing therapy, curing sickle cell disease and beta-thalassemia. One of the most significant medical breakthroughs in history. Has a pipeline of cancer and cardiovascular treatments.
Developing in-vivo CRISPR therapies — treatments that edit genes directly inside the patient's body rather than in a lab. This approach could treat diseases in organs that are difficult to reach. Early clinical results have been remarkable.
Linked to Gene Editing and Base Editing. Relies on Illumina. Competes with CRISPR Therapeutics and Intellia Therapeutics.
Linked to Gene Editing and Genomics. Relies on Illumina. Competes with CRISPR Therapeutics and Intellia Therapeutics.
Linked to Rare Disease and Gene Therapy. Relies on Thermo Fisher and Danaher. Competes with Regeneron and Amgen.
Linked to mRNA Technology and Personalised Medicine. Relies on Thermo Fisher and Danaher. Competes with Moderna and Pfizer.
Linked to Liquid Biopsy and Personalised Medicine. Customers include UnitedHealth. Competes with Illumina and Genomic Health.
Linked to AI in Drug Discovery. Customers include Pfizer and Johnson & Johnson. Competes with Veeva Systems and Moody's Analytics.
Want to explore how these companies connect to each other?